Merging thoughts II
This article was originally published in The Tan Sheet
Executive Summary
Merger discussions between SmithKline Beecham and Glaxo Wellcome have started up again, the companies announce Jan. 14. Changes in senior management since the last go-around, namely the pending departure of SB CEO Jan Leschly and the possible early retirement of Glaxo CEO Richard Sykes, may help talks progress more smoothly
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
People In Brief
Perrigo promotes in pricing, planning
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: